Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders Equity (Deficit)

v3.22.1
Condensed Consolidated Statements of Stockholders Equity (Deficit) - USD ($)
Common Stock
APIC
Accumulated Deficit
Accumulated other Comprehensive income
Non-Controlling InterestAccumulated Non-Controlling Stockholders'
Preferred Stock [Member]
Series B Preferred
Series B Preferred
Total
Balance at Dec. 31, 2020 $ 29,000 $ 240,821,000 $ (248,094,000)   $ (2,773,000) $ 2,477,000   $ (7,540,000)
Balance (in shares) at Dec. 31, 2020 29,249,925         3,973    
Stock-based compensation $ 0 101,000 0   0 $ 0   101,000
Stock issued under "at-the-market" offering $ 79,000 65,881,000 0   0 $ 0   65,960,000
Stock issued under "at-the-market" offering (in shares) 78,685,315         0    
Warrants Exercised $ 12,000 8,030,000 0   0 $ 0   8,042,000
Warrants Exercised (In shares) 11,655,747         0    
Series A Preferred Stock Dividends $ 0 0 (24,000)   0 $ 0   (24,000)
Conversion of Series A Preferred Stock to Common $ 9,000 12,813,000 0   0 $ 0   12,822,000
Conversion of Series A Preferred Stock to Common (in shares) 8,996,768         0    
Conversion of Series B Preferred Stock to Common $ 3,000 3,971,000 (1,497,000)   0 $ (2,477,000)   0
Conversion of Series B Preferred Stock to Common (in shares) 3,454,783         (3,973)    
Net loss $ 0 0 (2,536,000)   0 $ 0   (2,536,000)
Non-controlling interest 0 0 0   (1,000) 0 $ 100,000 (1,000)
Effect of Series A Preferred Stock price adjustment $ 0 7,402,000 (7,402,000)   0 $ 0   $ 0
Issuance of Common Stock, preferred Stock and Warrants in Units Offering, net of issuance costs (in shares)               78,700,000
Balance (in shares) at Mar. 31, 2021 132,042,538         0    
Balance at Mar. 31, 2021 $ 132,000 339,019,000 (259,553,000)   $ (2,774,000) $ 0   $ 76,824,000
Balance at Dec. 31, 2021 $ 132,000 336,560,000 (271,284,000) $ 0   $ 0   65,408,000
Balance (in shares) at Dec. 31, 2021 132,042,538         0    
Stock-based compensation $ 0 112,000 0 0   $ 0   112,000
Issuance of Common Stock for VCN Acquisition $ 26,000 6,573,000 0 0   $ 0   6,599,000
Issuance of Common Stock for VCN Acquisition (in shares) 26,395,303         0    
Translation gains (losses) $ 0 0 0 181,000   $ 0   $ 181,000
Warrants Exercised (In shares) 0             0
Conversion of Series A Preferred Stock to Common (in shares)           0    
Net loss $ 0 0 (4,273,000) 0   $ 0   $ (4,273,000)
Non-controlling interest               $ 0
Issuance of Common Stock, preferred Stock and Warrants in Units Offering, net of issuance costs (in shares)               0
Balance (in shares) at Mar. 31, 2022 158,437,841         0    
Balance at Mar. 31, 2022 $ 158,000 $ 343,245,000 $ (275,557,000) $ 181,000   $ 0   $ 68,027,000